DHG Pharmaceutical Joint Stock Company reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported revenue was VND 1,161,685.13 million compared to VND 944,449.74 million a year ago. Net income was VND 262,386.79 million compared to VND 201,308.88 million a year ago. Basic earnings per share from continuing operations was VND 1,943 compared to VND 1,482 a year ago.
For the nine months, revenue was VND 3,345,727.53 million compared to VND 2,909,669.66 million a year ago. Net income was VND 752,257.1 million compared to VND 606,723.65 million a year ago. Basic earnings per share from continuing operations was VND 5,569 compared to VND 4,467 a year ago.